Spectranetics Reports Second Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P on track for muted open as Middle East tensions weigh; AI stocks boost Nasdaq
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- S&P on track for muted open as Middle East tensions weigh; AI stocks boost Nasdaq
- Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal
Needham & Company Cuts Price Target on Spectranetics (SPNC) to $24 Following 2Q15
July 24, 2015 6:44 AM EDTNeedham & Company reiterated a Buy rating on Spectranetics (NASDAQ: SPNC), and cut the price target to $24.00 (from $39.00), following 2Q15 results. Revenue was $61.7M missing consensus of $62.2M. Non-GAAP EPS was reported at ($0.22) vs. consensus of ($0.29). SPNC lowered its 2015 revenue guidance from $258M to... More
Spectranetics (SPNC) Tops Q2 EPS by 18c; Lowers FY15 Revenue Outlook
July 23, 2015 4:18 PM EDTSpectranetics (NASDAQ: SPNC) reported Q2 EPS of ($0.13), $0.18 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $61.7 million versus the consensus estimate of $62.23 million.
Spectranetics sees FY2015 revenue of $240-250 million, versus prior guidance of $258.0 million and the consensus of $258.0... More
